Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
2011 ◽
Vol 29
(15_suppl)
◽
pp. 5517-5517
2009 ◽
Vol 65
(2)
◽
pp. 259-265
◽